Ana Belén García García

Title: Ana Belén García García: Innovator in Protein Kinase Inhibitors

Introduction

Ana Belén García García is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of macrocyclic compounds that serve as protein kinase inhibitors. With a total of 2 patents, his work is crucial in the ongoing fight against cancer.

Latest Patents

Ana's latest patents focus on macrocyclic compounds that inhibit protein kinases. These compounds are designed to treat diseases where the inhibition of specific protein or lipid kinases, such as PI3-K and mTOR, is necessary. The patents detail compounds of formula I, which include pharmaceutically acceptable esters, amides, solvates, or salts. The invention also encompasses combinations containing these compounds, highlighting their potential in cancer treatment.

Career Highlights

Ana is affiliated with the Fundación Centro Nacional de Investigaciones Oncológicas Carlos III, where he conducts his research. His work is characterized by a commitment to advancing cancer therapies through innovative chemical solutions. His contributions have been recognized within the scientific community, establishing him as a key figure in his field.

Collaborations

Ana collaborates with esteemed colleagues such as Rosario Concepción Riesco Fagundo and Antonio Rodríguez Hergueta. These partnerships enhance the research efforts and broaden the impact of their findings in the medical field.

Conclusion

Ana Belén García García is a dedicated inventor whose work on protein kinase inhibitors is paving the way for new cancer treatments. His innovative approach and collaboration with other experts underscore the importance of teamwork in scientific advancements.